| 000 | 01866nam a2200325 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 090223s2008 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.09.M.Sc.2008.Om.P | ||
| 100 | 0 | _aOmaima Ali Mohamed Kholify Ahmed | |
| 245 | 1 | 2 |
_aA pharmacological study on the effects of a calcium channel blocker and an antioxdant on the activity and toxicity of doxorubicin in tumour bearing mice / _cOmaima Ali Mohamed Kholify Ahmed ; supervised Afaf A. Ain Shoka , Abdelmoneim M. Osman , Hanan Salah Eldin Elabhar |
| 246 | 1 | 5 | _aدراسة فارماكولوجية لتأثير احد غالقات قنوات الكالسيوم واحد مضادات الأكسدة على فاعلية وسمية عقار الدوكسوروبسين فى الفئران حاملات الورم |
| 260 |
_aCairo : _bOmaima Ali Mohamed Kholify Ahmed , _c2008 |
||
| 300 |
_a177 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology | ||
| 520 | _aDoxorubiin(DXR)is one of the most commonly used anticancer drugs nevertheless cardiotoxicity myelo - suppression and nephrotoxicity besides the development of tumour resistane have limited its clinical use verapamil(VRP)was chosen to overcome tumour resistance and selenium(SE)is a known antioxidant and a free radical scavenging micronutrient | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAnti Angiogenic | |
| 653 | 4 | _aAntineoplastic | |
| 653 | 4 | _aVerapamil | |
| 700 | 0 |
_aAbdelmoneim Mahmoud Osman , _eSupervisor |
|
| 700 | 0 |
_aAfaf Abdelmoneim Ain Shoka , _eSupervisor |
|
| 700 | 0 |
_aHanan Salah Eldin Elabhar , _eSupervisor |
|
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c15111 _d15111 |
||